Cause of death, by non-communicable diseases, ages 15-59, female in Italy
Italy: Cause of death, by non-communicable diseases, ages 15-59, female was 85.8% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 15-59, female in Italy, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59, female in Italy stood at 85.8%.
The figure is up 0.2% on the previous year and down 3.2% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, female in Italy peaked at 89.6% in 2019 and was at its lowest, 85.6%, in 2020.
Italy ranks 2nd of 185 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 15-59, female in Italy, year by year
| Year | % of total female deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 86.1% | — |
| 2010 | 88.6% | +2.9% |
| 2015 | 88.9% | +0.3% |
| 2019 | 89.6% | +0.8% |
| 2020 | 85.6% | -4.5% |
| 2021 | 85.8% | +0.2% |
Italy compared with similar countries
- Italy's 85.8% is above the median for high income countries, which is 76.1%, 1.1× the median. (58 countries reporting)
- Italy's 85.8% is above the median for Europe & Central Asia, which is 73.2%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 86.1% | 86.1% | 86.1% | 1 |
| 2010s | 89.0% | 88.6% | 89.6% | 3 |
| 2020s | 85.7% | 85.6% | 85.8% | 2 |
Countries ranked near Italy
More health data for Italy
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1206 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,408 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.23 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0164 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.07 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, female in Italy?
- Cause of death, by non-communicable diseases, ages 15-59, female in Italy was 85.8% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, female recorded in Italy?
- The highest recorded value was 89.6% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, female recorded in Italy?
- The lowest recorded value was 85.6% in 2020.
- How does Italy rank for cause of death, by non-communicable diseases, ages 15-59, female?
- Italy ranks 2nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, female rising or falling in Italy?
- Over the last ten years it is down 3.2%. The long-run trend across the full record is flat.
- Where does this Italy data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.